Incyte Corp. (INCY)
99.85
+2.38
(+2.44%)
USD |
NASDAQ |
May 06, 16:00
98.85
-1.00
(-1.00%)
Pre-Market: 08:22
Incyte Market Cap : 19.95B for May 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 880.19B |
| ACADIA Pharmaceuticals, Inc. | 3.662B |
| Merck & Co., Inc. | 280.47B |
| Novartis AG | 283.08B |
| Madrigal Pharmaceuticals, Inc. | 12.44B |
Market Cap Related Metrics
| PE Ratio | 14.12 |
| PS Ratio | 3.780 |
| PEG Ratio | 0.0068 |
| Price to Book Value | 3.548 |
| Price to Free Cash Flow | 14.26 |
| Price | 99.85 |
| Earnings Yield | 7.08% |
| PEGY Ratio | 0.0068 |
| Operating PE Ratio | 13.97 |
| Normalized PE Ratio | 15.45 |